m1A Regulatory Gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma

Author:

Zhou Linjun1,Zhou Weidong2,Li Yuan3,Hua Ruifang1

Affiliation:

1. Guangdong Provincial People's Hospital Ganzhou Hospital, Ganzhou Municipal Hospital

2. Shangyou Hospital of Tradition Chinese Medicine

3. Tongji University School of Medicine

Abstract

Abstract Adenosine N1 methylation (m1A) of RNA, a type of post-transcriptional modification, has been shown to play a significant role in the progression of cancer. The objective of the current research was to analyze the genetic alteration and prognostic significance of m1A regulators in kidney renal clear cell carcinoma (KIRC). Genomic and clinicopathological characteristics were obtained from 558 KIRC patients in the Cancer Genome Atlas (TCGA) and Gene Omnibus Expression (GEO) databases. Alterations in the gene expression of ten m1A-regulators were analyzed and survival analysis was performed using the Cox regression method. We also identified three clusters of patients based on their distinct m1A alteration patterns, using integrated analysis of the ten m1A-related regulators, which were significantly related to overall survival (OS), disease free survival (DFS) and tumor microenvironment (TME) immune cell infiltration cells in KIRC. Our findings showed that m1A alteration patterns have critical roles in determining TME complexity and its immune cell composition. Furthermore, different m1A expression patterns were significantly associated with DFS and OS rates in KIRC patients. In conclusion, the identified m1A RNA modification patterns offer a potentially effective way to classify KIRC patients based on their TME immune cell infiltration, enabling the development of more personalized and successful treatment strategies for these patients.

Publisher

Research Square Platform LLC

Reference39 articles.

1. Kidney cancer: the next decade;Turajlic S;Journal of Experimental Medicine,2018

2. Epidemiology and clinicopathological profile of renal cell carcinoma: a review from tertiary care referral centre;Pallagani L;Journal of Kidney Cancer and VHL,2021

3. Review of adjuvant therapies in renal cell carcinoma: evidence to date;Tacconi EM;OncoTargets and therapy,2020

4. Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, et al., editors. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. Urologic Oncology: Seminars and Original Investigations; 2016: Elsevier.

5. Gender specific mutation incidence and survival associations in clear cell renal cell carcinoma (CCRCC);Ricketts CJ;PloS one,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3